0001288469-23-000158.txt : 20230822 0001288469-23-000158.hdr.sgml : 20230822 20230822183005 ACCESSION NUMBER: 0001288469-23-000158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230820 FILED AS OF DATE: 20230822 DATE AS OF CHANGE: 20230822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LITCHFIELD STEVEN G CENTRAL INDEX KEY: 0001286030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34666 FILM NUMBER: 231194774 MAIL ADDRESS: STREET 1: C/O MAXLINEAR, INC. STREET 2: 5966 LA PLACE COURT, SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAXLINEAR, INC CENTRAL INDEX KEY: 0001288469 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 141896129 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5966 LA PLACE CT. CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 760-692-0711 MAIL ADDRESS: STREET 1: 5966 LA PLACE CT. CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: MAXLINEAR INC DATE OF NAME CHANGE: 20040423 4 1 wk-form4_1692743396.xml FORM 4 X0508 4 2023-08-20 0 0001288469 MAXLINEAR, INC MXL 0001286030 LITCHFIELD STEVEN G C/O MAXLINEAR, INC. 5966 LA PLACE COURT, SUITE 100 CARLSBAD CA 92008 0 1 0 0 See remarks 0 Common Stock 2023-08-20 4 A 0 1260 0 A 363338 D Common Stock 2023-08-20 4 A 0 1655 0 A 364993 D Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the performance period ended July 2023 that were approved as part of the 2022 performance-based restricted stock award granted on July 29, 2022. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. The Reporting Person has deferred settlement of the shares pursuant to a Performance-Based Restricted Stock Unit Election Form entered into by the Reporting Person on September 15, 2022 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control. Chief Financial Officer and Chief Corporate Strategy Officer /s/ Connie Kwong, as Attorney-in-Fact 2023-08-22